Selumetinib-based therapy in uveal melanoma patient-derived xenograftsDidier Decaudin(Université Paris Sciences et Lettres), Fariba Némati(Université Paris Sciences et Lettres)OncotargetApril 24, 201810.18632/oncotarget.24670Cited by 24SaveCiteExport RISWatch citationsRelated PapersTargeting Bcl-2/Bcl-XL Induces Antitumor Activity in Uveal Melanoma Patient-Derived Xenografts|PLoS ONE|2014|49